| 3.2 |
9.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 2.9 |
8.7 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 2.7 |
8.0 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 2.6 |
7.7 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 2.5 |
7.5 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 2.5 |
7.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.1 |
6.3 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 2.0 |
6.1 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 1.9 |
13.6 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.9 |
1.9 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 1.8 |
10.9 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 1.8 |
16.1 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 1.8 |
5.3 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 1.8 |
19.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 1.6 |
4.9 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 1.6 |
6.4 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 1.6 |
6.3 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 1.6 |
4.7 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 1.5 |
4.6 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.5 |
6.2 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 1.5 |
3.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.5 |
6.0 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 1.5 |
4.4 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.4 |
4.2 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 1.4 |
4.2 |
GO:0046959 |
habituation(GO:0046959) |
| 1.4 |
4.2 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 1.4 |
4.1 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) negative regulation of urine volume(GO:0035811) regulation of renin secretion into blood stream(GO:1900133) |
| 1.3 |
5.4 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.3 |
10.6 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 1.3 |
18.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.3 |
7.7 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.3 |
3.8 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 1.2 |
3.7 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.2 |
3.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.2 |
3.6 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 1.2 |
3.5 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.2 |
1.2 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) |
| 1.2 |
5.8 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.2 |
4.6 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.2 |
8.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.1 |
2.3 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.1 |
7.9 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.1 |
5.6 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 1.1 |
2.2 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 1.1 |
1.1 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 1.0 |
4.2 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 1.0 |
5.2 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.0 |
4.1 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.0 |
4.1 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 1.0 |
2.9 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.9 |
13.0 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.9 |
10.1 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.9 |
8.2 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.9 |
3.5 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.9 |
1.8 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.9 |
8.7 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.9 |
3.5 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.9 |
2.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.9 |
2.6 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.8 |
4.2 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.8 |
2.5 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.8 |
0.8 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.8 |
3.3 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.8 |
2.5 |
GO:0035878 |
nail development(GO:0035878) |
| 0.8 |
2.5 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.8 |
1.6 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.8 |
3.2 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.8 |
4.8 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.8 |
4.0 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.8 |
2.4 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.8 |
4.8 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.8 |
4.0 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.8 |
2.3 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.8 |
1.5 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.8 |
10.6 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.8 |
3.0 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.8 |
3.8 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.7 |
5.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.7 |
2.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.7 |
2.2 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.7 |
2.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.7 |
0.7 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.7 |
4.3 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.7 |
0.7 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.7 |
10.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.7 |
2.1 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.7 |
2.1 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.7 |
2.1 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.7 |
2.1 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.7 |
2.1 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.7 |
2.1 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.7 |
4.1 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
| 0.7 |
1.4 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.7 |
0.7 |
GO:0003222 |
ventricular trabecula myocardium morphogenesis(GO:0003222) |
| 0.7 |
2.7 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.7 |
3.4 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.7 |
2.7 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.7 |
2.7 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.7 |
2.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 |
5.9 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.6 |
3.2 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.6 |
1.9 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.6 |
1.9 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.6 |
0.6 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.6 |
3.8 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.6 |
2.5 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.6 |
1.9 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.6 |
0.6 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.6 |
1.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.6 |
1.9 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 |
1.3 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.6 |
0.6 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.6 |
1.9 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.6 |
4.3 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.6 |
2.5 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.6 |
3.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.6 |
0.6 |
GO:0072698 |
protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.6 |
3.7 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 |
1.8 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.6 |
2.4 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.6 |
5.3 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.6 |
0.6 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.6 |
1.8 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.6 |
1.2 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.6 |
0.6 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.6 |
1.1 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.6 |
4.6 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.6 |
3.4 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.6 |
1.7 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.6 |
2.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.6 |
1.7 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.6 |
0.6 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.6 |
5.0 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.6 |
1.1 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.5 |
1.6 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.5 |
3.3 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
2.7 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.5 |
1.6 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.5 |
2.6 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.5 |
1.6 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.5 |
2.1 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.5 |
0.5 |
GO:0060915 |
fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.5 |
2.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.5 |
1.6 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.5 |
1.0 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.5 |
1.0 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.5 |
2.6 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.5 |
1.0 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.5 |
1.5 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.5 |
1.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.5 |
0.5 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.5 |
2.0 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.5 |
2.5 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.5 |
1.5 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.5 |
2.0 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.5 |
3.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.5 |
1.5 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.5 |
2.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.5 |
2.0 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.5 |
0.5 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.5 |
7.8 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.5 |
1.0 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.5 |
2.9 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.5 |
1.9 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.5 |
0.5 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.5 |
1.4 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.5 |
2.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.5 |
2.3 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.5 |
1.4 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.5 |
1.4 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.5 |
0.9 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.5 |
1.9 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.5 |
1.4 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.5 |
2.8 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.5 |
0.5 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.5 |
1.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.5 |
1.4 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.5 |
1.4 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.4 |
1.3 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.4 |
0.9 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.4 |
0.4 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.4 |
1.8 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.4 |
0.9 |
GO:0021548 |
pons development(GO:0021548) |
| 0.4 |
1.3 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.4 |
2.2 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.4 |
1.7 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.4 |
8.7 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.4 |
0.9 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.4 |
0.4 |
GO:0046467 |
membrane lipid biosynthetic process(GO:0046467) |
| 0.4 |
0.9 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.4 |
0.4 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.4 |
0.4 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.4 |
1.3 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.4 |
1.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.4 |
2.1 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.4 |
1.3 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 |
0.4 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.4 |
0.8 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.4 |
2.1 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.4 |
1.2 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.4 |
1.7 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.4 |
2.9 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.4 |
5.8 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.4 |
0.4 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.4 |
3.3 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.4 |
2.5 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.4 |
1.2 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.4 |
0.8 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.4 |
2.4 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.4 |
2.4 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.4 |
3.2 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.4 |
6.4 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.4 |
1.6 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.4 |
11.6 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.4 |
1.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.4 |
1.2 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.4 |
2.0 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 |
0.4 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.4 |
2.8 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.4 |
4.7 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.4 |
0.8 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.4 |
0.4 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.4 |
0.8 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.4 |
3.1 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.4 |
1.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.4 |
9.6 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 |
1.5 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 |
3.4 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.4 |
1.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 |
1.5 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.4 |
0.7 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.4 |
0.4 |
GO:0010612 |
regulation of cardiac muscle adaptation(GO:0010612) |
| 0.4 |
1.8 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.4 |
0.4 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.4 |
1.1 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.4 |
1.5 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.4 |
0.7 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.4 |
0.4 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.4 |
1.1 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.4 |
0.4 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.4 |
0.4 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.4 |
0.7 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.4 |
0.7 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.4 |
2.1 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.4 |
0.7 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.4 |
1.4 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 0.4 |
1.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.4 |
0.4 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.4 |
0.7 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.4 |
1.1 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.3 |
0.7 |
GO:0051788 |
response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
| 0.3 |
1.7 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.3 |
1.4 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.3 |
1.7 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 |
7.3 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.3 |
2.1 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.3 |
1.7 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.3 |
8.2 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.3 |
1.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 |
1.7 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.3 |
2.0 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.3 |
0.3 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.3 |
0.7 |
GO:0021955 |
central nervous system neuron axonogenesis(GO:0021955) |
| 0.3 |
1.7 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.3 |
3.7 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 |
1.3 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.3 |
1.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.3 |
1.0 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.3 |
1.6 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 |
2.6 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.3 |
1.9 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.3 |
0.3 |
GO:0040038 |
meiotic cytokinesis(GO:0033206) polar body extrusion after meiotic divisions(GO:0040038) |
| 0.3 |
1.0 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 |
0.3 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.3 |
1.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.3 |
1.3 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 |
1.0 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.3 |
4.1 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.3 |
0.3 |
GO:0003171 |
atrioventricular valve development(GO:0003171) |
| 0.3 |
0.6 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 |
1.3 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.3 |
1.2 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.3 |
5.9 |
GO:0051654 |
establishment of mitochondrion localization(GO:0051654) |
| 0.3 |
0.3 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.3 |
0.9 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.3 |
0.9 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.3 |
3.4 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.3 |
3.7 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.3 |
2.8 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.3 |
1.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
1.5 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.3 |
1.5 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.3 |
0.3 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.3 |
0.9 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.3 |
0.9 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 |
0.3 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.3 |
3.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.3 |
0.9 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
0.6 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.3 |
0.9 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
0.9 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 |
1.5 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.3 |
0.9 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 |
0.6 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.3 |
3.8 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.3 |
0.6 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.3 |
1.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.3 |
1.4 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 |
3.5 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.3 |
0.6 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.3 |
0.9 |
GO:0072506 |
phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.3 |
1.4 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.3 |
0.3 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.3 |
1.7 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
0.8 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.3 |
2.0 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.3 |
2.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 |
2.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.3 |
2.0 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.3 |
1.1 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.3 |
1.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.3 |
0.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.3 |
0.8 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.3 |
1.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.3 |
0.5 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.3 |
0.8 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.3 |
1.6 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.3 |
0.8 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 |
0.3 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.3 |
2.2 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 |
1.1 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.3 |
1.1 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.3 |
2.7 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.3 |
0.8 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.3 |
2.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
1.9 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.3 |
1.3 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.3 |
0.8 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.3 |
0.8 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.3 |
1.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.3 |
0.8 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.3 |
0.5 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.3 |
0.8 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.3 |
1.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 |
1.6 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) |
| 0.3 |
1.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.3 |
1.0 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.3 |
1.0 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.3 |
0.3 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 |
1.8 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.3 |
1.0 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.3 |
0.3 |
GO:0098910 |
regulation of atrial cardiac muscle cell action potential(GO:0098910) |
| 0.3 |
0.8 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.3 |
1.8 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.3 |
1.3 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.3 |
2.5 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.3 |
0.5 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.3 |
1.0 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.3 |
1.0 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.3 |
1.0 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 |
1.0 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.3 |
2.0 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.3 |
1.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 |
0.8 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.2 |
1.5 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.2 |
0.5 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 |
2.2 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.2 |
0.2 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 |
3.2 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.2 |
2.0 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
1.0 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
0.7 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.2 |
0.5 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 |
0.2 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 |
0.2 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.2 |
1.2 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.2 |
0.2 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.2 |
0.7 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.2 |
0.5 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
1.0 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.7 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.2 |
0.5 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.2 |
0.5 |
GO:0090178 |
regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
| 0.2 |
4.7 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
3.0 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.2 |
0.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
0.9 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
1.2 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.2 |
0.7 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
1.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
0.2 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.2 |
0.2 |
GO:0031622 |
fever generation(GO:0001660) regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
| 0.2 |
1.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
2.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.2 |
3.9 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 |
0.7 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.2 |
0.7 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 |
0.2 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.2 |
1.1 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 |
3.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.2 |
1.1 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 |
1.4 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
0.7 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.2 |
1.8 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.2 |
2.5 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 |
0.4 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.2 |
0.4 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 |
0.9 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.2 |
0.4 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.2 |
3.7 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.2 |
0.2 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.2 |
2.0 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.2 |
0.6 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
4.7 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.2 |
0.4 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.2 |
1.1 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.2 |
0.6 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
1.1 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 |
6.4 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.2 |
1.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
0.8 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
1.7 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
0.4 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.2 |
0.8 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.2 |
1.0 |
GO:0099515 |
nuclear migration along microfilament(GO:0031022) actin filament-based transport(GO:0099515) |
| 0.2 |
0.2 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.2 |
0.2 |
GO:0050942 |
positive regulation of pigment cell differentiation(GO:0050942) |
| 0.2 |
3.1 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 |
2.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.2 |
0.6 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.2 |
2.9 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.2 |
0.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.2 |
1.8 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
0.4 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.2 |
1.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 |
0.8 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 |
0.2 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.2 |
1.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.2 |
0.8 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.2 |
5.0 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.2 |
0.6 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 |
1.2 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
1.0 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
0.4 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.2 |
0.2 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 |
1.0 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
0.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.2 |
1.0 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.2 |
0.4 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.2 |
1.4 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.2 |
0.6 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.2 |
0.4 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 |
0.6 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
0.6 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 |
0.6 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.6 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.2 |
0.4 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.2 |
0.6 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.2 |
0.4 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 |
1.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
0.4 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.2 |
1.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.2 |
0.6 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.2 |
4.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.2 |
2.6 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
0.6 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.2 |
0.2 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.2 |
2.8 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.2 |
0.2 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
0.6 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.2 |
0.7 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
| 0.2 |
0.4 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.2 |
0.4 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 |
1.6 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
0.5 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 |
1.8 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.2 |
0.7 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.2 |
0.9 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.2 |
0.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
0.7 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.2 |
0.4 |
GO:0071864 |
positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.2 |
0.4 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.2 |
1.2 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
0.7 |
GO:0035809 |
regulation of urine volume(GO:0035809) positive regulation of urine volume(GO:0035810) |
| 0.2 |
0.2 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.2 |
0.2 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.2 |
1.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.2 |
0.4 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.2 |
0.4 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.2 |
0.9 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 |
1.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
2.1 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 |
0.9 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
0.5 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.2 |
1.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
0.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
0.7 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.2 |
0.3 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.2 |
0.7 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.2 |
0.3 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 |
0.9 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.2 |
0.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
0.5 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.2 |
0.8 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 |
0.5 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
0.7 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.2 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.2 |
1.3 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
3.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
1.0 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 |
1.3 |
GO:0086103 |
G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.2 |
0.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.2 |
3.5 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.2 |
0.8 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.2 |
0.5 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.2 |
2.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 |
1.0 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
0.3 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.2 |
0.5 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.2 |
1.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.2 |
1.0 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.2 |
0.5 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.2 |
1.6 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 |
0.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 |
1.0 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
2.4 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.2 |
0.8 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.2 |
1.7 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.2 |
1.1 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
1.1 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.2 |
0.6 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
0.2 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.2 |
0.8 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.2 |
0.6 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 |
0.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.2 |
23.5 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.2 |
0.3 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.2 |
2.0 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
0.3 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.2 |
2.9 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.2 |
2.0 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.2 |
0.9 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
0.3 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.1 |
0.4 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.6 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
1.0 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.9 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.1 |
1.6 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.1 |
0.4 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
4.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
1.0 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 |
0.9 |
GO:0002093 |
auditory receptor cell morphogenesis(GO:0002093) |
| 0.1 |
8.1 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.7 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.7 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
3.5 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
0.1 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
1.6 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.4 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.1 |
1.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
1.0 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.6 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.7 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
1.0 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
1.0 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
0.3 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.1 |
0.4 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.3 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.1 |
0.8 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.8 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.3 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 |
0.8 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
7.9 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.7 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.7 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
3.4 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.1 |
1.1 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 |
1.5 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 |
0.3 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.1 |
0.8 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
0.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.9 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
1.1 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.1 |
1.9 |
GO:0031061 |
negative regulation of histone methylation(GO:0031061) |
| 0.1 |
0.5 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.7 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.7 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
3.1 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.1 |
0.7 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.5 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
2.5 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
0.1 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
| 0.1 |
1.4 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.1 |
0.5 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.4 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.1 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.1 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
3.4 |
GO:0050879 |
multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 |
0.1 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.1 |
0.3 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
2.1 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
2.6 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.1 |
0.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
1.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.8 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.1 |
0.8 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.5 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
0.4 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
2.5 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.5 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 |
0.4 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.4 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.6 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
0.3 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.1 |
2.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.6 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
1.0 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.4 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 |
0.5 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.5 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
1.5 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.5 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
1.2 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.7 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.4 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.1 |
0.4 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.1 |
0.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.4 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
1.0 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.4 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 |
1.1 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
2.7 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.7 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.8 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.5 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.3 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.1 |
0.7 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
2.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.4 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
1.1 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.3 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.1 |
0.5 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 |
0.5 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.2 |
GO:1903431 |
positive regulation of cell maturation(GO:1903431) |
| 0.1 |
1.1 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.4 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 |
0.1 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 |
2.8 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.1 |
0.7 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.1 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.1 |
0.5 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.1 |
0.4 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
0.2 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.1 |
1.1 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.4 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.1 |
0.2 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 |
0.3 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.7 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.1 |
0.2 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
1.7 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.1 |
0.3 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.1 |
0.3 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.1 |
0.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.3 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
0.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.6 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
1.0 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 |
0.2 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
2.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
1.2 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) |
| 0.1 |
0.2 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.1 |
1.1 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.1 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.1 |
0.6 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.6 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 |
0.7 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.7 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.2 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 |
0.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 |
0.4 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.1 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.1 |
0.6 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 |
0.1 |
GO:0090177 |
establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.1 |
0.2 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.1 |
0.5 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
1.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.5 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
2.5 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.1 |
0.5 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.1 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.1 |
1.2 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
1.0 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.4 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
0.8 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.1 |
2.1 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.2 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
1.8 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.3 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
1.4 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
1.8 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
2.0 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.3 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) positive regulation of female receptivity(GO:0045925) |
| 0.1 |
7.8 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.1 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.1 |
0.6 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
2.9 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
0.9 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.2 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.6 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
0.2 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 |
0.2 |
GO:0006154 |
adenosine catabolic process(GO:0006154) |
| 0.1 |
3.6 |
GO:0070613 |
regulation of protein processing(GO:0070613) |
| 0.1 |
0.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.7 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.4 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
0.3 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
1.8 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.2 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.2 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 |
0.2 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
0.4 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.3 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 |
0.2 |
GO:0034239 |
regulation of macrophage fusion(GO:0034239) |
| 0.1 |
0.2 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.4 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.1 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.1 |
0.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.4 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
0.4 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.5 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.2 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.1 |
0.5 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
2.0 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.1 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.1 |
0.8 |
GO:0030149 |
sphingolipid catabolic process(GO:0030149) |
| 0.1 |
0.6 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.2 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.2 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.1 |
0.2 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.2 |
GO:0006097 |
glyoxylate cycle(GO:0006097) glyoxylate metabolic process(GO:0046487) |
| 0.1 |
0.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.4 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.3 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.6 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.1 |
0.1 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 |
0.4 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.1 |
GO:1903392 |
negative regulation of adherens junction organization(GO:1903392) |
| 0.1 |
0.3 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 |
0.4 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
0.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.1 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.2 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 |
0.1 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
1.0 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.7 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.6 |
GO:0042921 |
glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 |
0.3 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.1 |
0.4 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.1 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.1 |
0.6 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.1 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.4 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
0.3 |
GO:1902861 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) copper ion import into cell(GO:1902861) |
| 0.1 |
0.4 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
6.8 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.1 |
0.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.2 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.1 |
0.3 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.1 |
0.1 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
4.0 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
0.2 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.1 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.1 |
0.1 |
GO:1902914 |
regulation of protein polyubiquitination(GO:1902914) |
| 0.1 |
0.2 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.5 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.1 |
0.5 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.1 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.5 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.1 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.1 |
1.9 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.1 |
0.2 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 |
0.3 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.5 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
0.6 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.1 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.2 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 |
1.2 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.1 |
0.1 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
0.6 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.1 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
0.6 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.1 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.1 |
0.1 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.2 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.1 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.1 |
0.3 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.2 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
4.3 |
GO:0046330 |
positive regulation of JNK cascade(GO:0046330) |
| 0.1 |
0.1 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
0.5 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
2.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.2 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.1 |
0.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.4 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.1 |
GO:1901859 |
negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.1 |
0.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.2 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.1 |
0.2 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.1 |
1.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.1 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
0.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.1 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
1.5 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.6 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.3 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.0 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.6 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.2 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.0 |
2.1 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
1.0 |
GO:0019226 |
transmission of nerve impulse(GO:0019226) |
| 0.0 |
0.3 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.2 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
3.5 |
GO:0030705 |
cytoskeleton-dependent intracellular transport(GO:0030705) |
| 0.0 |
0.1 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.0 |
0.5 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
0.2 |
GO:0071839 |
apoptotic process in bone marrow(GO:0071839) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.0 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.0 |
0.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
3.9 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
2.3 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.3 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.3 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.1 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.5 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.2 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 |
0.8 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.0 |
0.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.3 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.2 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.0 |
0.0 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.0 |
0.5 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.1 |
GO:0010970 |
establishment of localization by movement along microtubule(GO:0010970) |
| 0.0 |
0.1 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.1 |
GO:0043987 |
histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
| 0.0 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.1 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.0 |
0.2 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.0 |
0.1 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.0 |
0.1 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.0 |
0.0 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.0 |
0.1 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.3 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 |
1.3 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 |
0.3 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 |
0.2 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.1 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
0.2 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.1 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 |
0.2 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
0.4 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
0.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.0 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.0 |
0.1 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.0 |
0.1 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
0.1 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.0 |
0.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 |
0.1 |
GO:0051193 |
regulation of cofactor metabolic process(GO:0051193) |
| 0.0 |
0.1 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.2 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.2 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 |
0.2 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.0 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.5 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.1 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.0 |
0.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.1 |
GO:0051567 |
histone H3-K9 methylation(GO:0051567) |
| 0.0 |
0.1 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.1 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.9 |
GO:0043631 |
mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.0 |
0.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.0 |
0.7 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.0 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.0 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 |
0.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.0 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.8 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.0 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.0 |
0.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.0 |
0.1 |
GO:0043038 |
amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.0 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.1 |
GO:0021801 |
cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
| 0.0 |
0.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.5 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.1 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.2 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.0 |
0.1 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.2 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.2 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.1 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.0 |
0.2 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 |
0.2 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.1 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.0 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.0 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 |
0.0 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.1 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.1 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.0 |
0.0 |
GO:0006901 |
vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 |
0.1 |
GO:0003091 |
renal water homeostasis(GO:0003091) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.0 |
GO:1902548 |
negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.0 |
0.2 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.1 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 |
0.1 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.2 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.3 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 |
0.4 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.0 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.0 |
0.2 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.0 |
GO:0071929 |
NLRP3 inflammasome complex assembly(GO:0044546) alpha-tubulin acetylation(GO:0071929) regulation of NLRP3 inflammasome complex assembly(GO:1900225) positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.2 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.0 |
GO:0030878 |
thyroid gland development(GO:0030878) |
| 0.0 |
0.0 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.0 |
0.1 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.0 |
0.1 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 |
0.0 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.0 |
0.1 |
GO:0050658 |
nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
| 0.0 |
0.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.0 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.2 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.0 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.0 |
0.1 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.0 |
0.2 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.0 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.0 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.0 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.0 |
0.2 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.0 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.2 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.0 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.1 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.1 |
GO:0006188 |
IMP biosynthetic process(GO:0006188) |
| 0.0 |
0.1 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.0 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.0 |
0.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.1 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.0 |
0.0 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.0 |
0.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.0 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.0 |
GO:1905097 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.0 |
0.0 |
GO:0046519 |
sphingoid metabolic process(GO:0046519) |
| 0.0 |
0.0 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
